Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Metabolism. 2018 Jan 4;82:118–123. doi: 10.1016/j.metabol.2017.12.012

Table 1.

Subjects’ characteristics, respiratory chamber, and magnetic resonance imaging data.

Non-Diabetics Patients Type 2 Diabetics Patients
Gender (Male/Female) 31/31 23/21
Race (%White/Black/Other) 47/50/3 84/16/0
Age (years) 32.7 ± 10.80 57.7 ± 7.9*
Weight (kg) 97.8 ± 31.8 95.9 ± 23.4
Height (cm) 171.4 ± 9.9 170.2 ± 10.0
BMI (kg/m2) 33.6 ± 11.8 32.7 ± 7.2
Fat mass (kg) 31.6 ± 22.7 33.0 ± 14.7
Fat-free mass (kg) 59.3 ± 11.0 61.8 ± 11.8
Percent body fat (%) 32.2 ± 15.6 34.0 ± 9.2
Free fatty acids (mmol/L) 0.421 ± 0.241 0.578 ± 0.142*
Triglycerides (mg/dL) 93.0 ± 51.4 179.0 ± 123.0*
Total Cholesterol (mg/dL) 184.0 ± 29.4 170.2 ± 10.0
Glucose (mg/dL) 94.0 ± 8.3 116.6 ± 22.2*
Insulin (mU/L) 11.8 ± 10.7 19.4 ± 18.3*
HOMA-IR 2.8 ± 2.6 5.9 ± 6.4*
24 hour RQ 0.889 ± 0.045 0.865 ± 0.032
Sleep RQ 0.874 ± 0.055 0.850 ± 0.038
Fat oxidation (g/24hr/kgFFM) 0.95 ± 0.87 1.29 ± 0.48
Carbohydrate oxidation (g/24hr/kgFFM) 5.15 ± 1.51 4.41 ± 1.11
Soleus IMCL (% of oil signal) 0.46 ± 0.25 0.71 ± 0.60
Anterior Tibialis IMCL (% of oil signal) 0.38 ± 0.20 0.79 ± 1.01
Intrahepatic lipids (% of oil signal) 0.02 ± 0.03 0.09 ± 0.12

Absolute unadjusted values are shown in the table. For statistical analyses, all estimates were adjusted for sex, age, and BMI and presented as mean ± SD. G=grams, hr=hour. kgFFM= kilograms of fat-free mass. IMCL = intramyocellular lipids. Data presented as mean ± standard deviation.

*

p<0.05